Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: Is Caffeine an Environmental Modifier in Huntington's Disease?

View source ↗

Summary

A completed clinical trial investigates whether caffeine acts as an environmental modifier in Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Lille | Conditions: Huntington Disease | Status: COMPLETED